N6-(6-Aminohexyl)-adenosine-5'-triphosphate, Sodium salt
For research use only!
Shipping: shipped on gel packs
Storage Conditions: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible.
Shelf Life: 12 months after date of delivery
Molecular Formula: C16H29N6O13P3 (free acid)
Molecular Weight: 606.36 g/mol (free acid)
Exact Mass: 606.10 g/mol (free acid)
Purity: ≥ 95 % (HPLC)
Form: solution in water
Color: colorless to slightly yellow
Concentration: 10 mM - 11 mM
pH: 7.5 ±0.5
Spectroscopic Properties: λmax 266 nm, ε 16.2 L mmol-1 cm-1 (Tris-HCl pH 7.5)
Agonistic ligand, mainly for nucleoside receptor A1
Nucleoside-triphosphates can be converted by different membrane-bound phosphatases into nucleosides acting as nucleoside receptor ligands. In some cases nucleoside phosphates act also directly on nucleoside receptors.
Please click the black arrow on the right to expand the citation list. Click publication title for the full text.
 Komori et al. (2008) Measurement system for simultaneous observation of myosin V chemical and mechanical events. BioSystems 93:48.
 Williamson et al. (2009) Novel adenosine derived inhibitors of 70 kDa Heat Shock Protein, discovered through structure based design. J. Med. Chem. 52:1510.
 Teramoto et al. (2000) In vitro selection of a ligase ribozyme carrying alkylamino groups in the side chains. Bioconjugate Chem. 11:744.
 Folsom et al. (1989) Detection of DNA targets with biotinylated and fluoresceinated RNA probes. Effect of the extent of derivatization on detection sensitivy. Analytic. Biochem. 182:309.
Sirci et al. (2012) Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonists. J. Comput. Aided Mol. Des. 26:1247.
Volonte et al. (2009) Membrane components and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J. 276:318.
Yegutkin (2008) Nucleotide and nucleoside converting enzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783:673.
Joshi et al. (2005) Purine derivatives as ligands for A3 adenosine receptors. Current Topics in Medicinal Chemistry 5:1275.
Hess (2001) Recent advantages in adenosine receptor antagonist research. Expert Opin. Ther. Patents 11 (10):1533.
Jacobson (2001) Probing adenosine and P2 receptors: design of novel purines and nonpurines as selective ligands. Drug Development Res. 52:178.
Jacobson et al. (2001) Ribose modified nucleosides and nucleotides as ligands for purine receptors. Nucleosides, Nucleotides & Nucleic Acids 20 (4):333.
Ito et al. (1998) Modified nucleic acid for systematic evolution of RNA ligands by exponential enrichment. J. Bioact. Compat. Pol. 13 (2):114.
Trayer (1974) Affinity chromatography of some adenosine phosphate-requiring systems. Biochem. Soc. T. 2 (6):1302.
Van Galen et al. (1994) A binding site model and structure-activity relationships for rat A3 adenosine receptor. Molecular Pharmacology 45:1101.
Trayer et al. (1974) Preparation of adenosine nucleotide derivatives suitable for affinity chromatography. Biochem. J. 139 (3):609.